StemCyte is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular therapies. It has operations in the United States, Taiwan, and India. The company has cooperated with more than 350 medical transplant centers around the world, and has successfully assisted in the treatment of more than 2,200 patients using cord blood transplants. StemCyte considers umbilical cord blood banking its c...
StemCyte is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular therapies. It has operations in the United States, Taiwan, and India. The company has cooperated with more than 350 medical transplant centers around the world, and has successfully assisted in the treatment of more than 2,200 patients using cord blood transplants. StemCyte considers umbilical cord blood banking its core competence, while actively pursuing new regenerative cell therapy indications, including spinal cord injury, Long COVID treatment, acute stroke, cerebral palsy and cancers.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.